Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (281-290 of 340) with videos related to

Pageof 34
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximabPaula Sousa, Marta Patita, Bruno Arroja, et al.
Inflammatory Bowel Diseases|October 14, 2009
Ulcerative colitis in a Southern European country: a national perspectiveFrancisco Portela, Fernando Magro, Paula Lago, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meetingTommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Nature Reviews. Gastroenterology & Hepatology|August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel diseasePablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Scandinavian Journal of Gastroenterology|May 28, 2020
Methylation patterns in dysplasia in inflammatory bowel disease patientsIsadora Rosa, Patrícia Silva, Sara da Mata, et al.
Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Pageof 34

Showing results (281-290 of 340) with videos related to

Sort By:
Pageof 34
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximabPaula Sousa, Marta Patita, Bruno Arroja, et al.
Inflammatory Bowel Diseases|October 14, 2009
Ulcerative colitis in a Southern European country: a national perspectiveFrancisco Portela, Fernando Magro, Paula Lago, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meetingTommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Nature Reviews. Gastroenterology & Hepatology|August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel diseasePablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Scandinavian Journal of Gastroenterology|May 28, 2020
Methylation patterns in dysplasia in inflammatory bowel disease patientsIsadora Rosa, Patrícia Silva, Sara da Mata, et al.
Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Pageof 34